Digestive Enzyme Tablet in pharma franchise in Gujarat

Digestive Enzyme Tablet in PCD pharma franchise in Chennai

Digestive Enzyme Tablet in top pharma company in Surat

Digestive Enzyme Tablet in pcd pharma supplier in Lucknow

Digestive Enzyme Tablet in phama franchise company in India
Digestive Enzyme Tablet in phama distributor in Bhopal

Home/Products /pancreatin-300mg-lipase-activity-25000-ph-eur-units-amylase-activity-20000-ph-tablet

About the Product

Description


Pacrint 25K Tablet is a digestive enzyme supplement that contains Pancreatin 300mg, Lipase Activity 25,000 Ph Eur Units, Amylase Activity 20,000 Ph Eur Units, and Protease Activity 1,000 Ph Eur Units. This combination is specifically designed to assist with digestion by providing essential enzymes that break down fats, proteins, and carbohydrates in the digestive tract.

  • Pancreatin contains a blend of digestive enzymes, including Lipase, Amylase, and Protease, that help to digest fats, carbohydrates, and proteins, respectively.
  • Lipase breaks down fats, ensuring better absorption of fat-soluble vitamins and fatty acids.
  • Amylase aids in the digestion of starches and carbohydrates, while Protease assists in breaking down proteins into their absorbable components.

Pacrint 25K Tablet is typically used to support digestion in individuals with pancreatic insufficiency or other conditions that affect enzyme production and digestion. It is commonly prescribed in cases such as chronic pancreatitis, cystic fibrosis, or after pancreatic surgery, where the body’s natural enzyme production is insufficient.

Side effects may include stomach discomfort, bloating, or allergic reactions. Consult a doctor if any unusual symptoms occur.

Used to support digestion in individuals with pancreatic insufficiency, chronic pancreatitis, cystic fibrosis, or after pancreatic surgery.

Use as directed by a healthcare professional. Not recommended for individuals with a known hypersensitivity to pancreatin or pork-derived products.

Store in a cool, dry place, away from direct sunlight. Keep out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Frequently Asked Questions

1. What are the business opportunities for Pancreatin 300 mg + Lipase 25,000 Ph Eur Units + Amylase 20,000 Ph Eur Units + Protease 1,000 Ph Eur Units Tablet in the PCD pharma franchise market?

This formulation is a pancreatic enzyme replacement therapy (PERT) used for the management of digestive enzyme deficiency, pancreatic insufficiency, chronic pancreatitis, cystic fibrosis-related malabsorption, indigestion, bloating, and poor nutrient absorption. Pancreatin provides essential digestive enzymes—lipase for fats, amylase for carbohydrates, and protease for proteins—supporting complete digestion and nutrient assimilation. It is a valuable gastroenterology and digestive enzyme segment product for medical distributors, wholesalers, and pharma franchise partners in the PCD pharma franchise market.

2. Why should medical distributors include this tablet in their range?

Medical distributors and wholesalers can benefit from consistent demand from gastroenterologists, hepatologists, diabetologists, and multispecialty hospitals. Digestive enzyme deficiencies and chronic pancreatic disorders require long-term therapy, ensuring regular prescriptions, repeat purchases, and stable institutional demand.

3. Does Cafoli Lifecare offer PCD pharma franchise opportunities for this product?

Yes, Cafoli Lifecare offers PCD pharma franchise opportunities in the gastroenterology, digestive enzyme therapy, and chronic care segments with monopoly rights, quality manufacturing standards, promotional support, and reliable supply services for distributors and medical agencies.

4. What benefits do wholesalers get by partnering for this digestive enzyme tablet?

Wholesalers and healthcare suppliers benefit from long-term chronic therapy usage, specialist-driven prescriptions, increasing awareness of digestive health disorders, and continuous hospital demand, making it a stable and high-value pharmaceutical category when partnered with Cafoli Lifecare.

5. How can I become a distributor or franchise partner for this enzyme tablet?

Medical distributors, stockists, and pharma professionals interested in gastrointestinal and enzyme replacement formulations can contact Cafoli Lifecare to discuss product availability, pricing structure, and PCD pharma franchise opportunities in the digestive care segment.